AU2014278708B2 - Tetrapeptides derived from human C-X-C chemokines useful for treatment of various skin conditions - Google Patents

Tetrapeptides derived from human C-X-C chemokines useful for treatment of various skin conditions Download PDF

Info

Publication number
AU2014278708B2
AU2014278708B2 AU2014278708A AU2014278708A AU2014278708B2 AU 2014278708 B2 AU2014278708 B2 AU 2014278708B2 AU 2014278708 A AU2014278708 A AU 2014278708A AU 2014278708 A AU2014278708 A AU 2014278708A AU 2014278708 B2 AU2014278708 B2 AU 2014278708B2
Authority
AU
Australia
Prior art keywords
skin
tetrapeptide
seq
wound
chemokine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014278708A
Other languages
English (en)
Other versions
AU2014278708A1 (en
Inventor
Robin Carmichael
Lijuan Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helix Biomedix Inc
Original Assignee
Helix Biomedix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helix Biomedix Inc filed Critical Helix Biomedix Inc
Publication of AU2014278708A1 publication Critical patent/AU2014278708A1/en
Application granted granted Critical
Publication of AU2014278708B2 publication Critical patent/AU2014278708B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
AU2014278708A 2013-06-14 2014-05-14 Tetrapeptides derived from human C-X-C chemokines useful for treatment of various skin conditions Active AU2014278708B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361835424P 2013-06-14 2013-06-14
US61/835,424 2013-06-14
PCT/US2014/037978 WO2014200651A1 (en) 2013-06-14 2014-05-14 Tetrapeptides derived from human c-x-c chemokines useful for treatment of various skin conditions

Publications (2)

Publication Number Publication Date
AU2014278708A1 AU2014278708A1 (en) 2015-12-24
AU2014278708B2 true AU2014278708B2 (en) 2017-12-07

Family

ID=50943603

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014278708A Active AU2014278708B2 (en) 2013-06-14 2014-05-14 Tetrapeptides derived from human C-X-C chemokines useful for treatment of various skin conditions

Country Status (21)

Country Link
US (1) US10195245B2 (enExample)
EP (1) EP3007716B1 (enExample)
JP (1) JP6416240B2 (enExample)
KR (1) KR102254260B1 (enExample)
CN (1) CN105324122B (enExample)
AR (1) AR096594A1 (enExample)
AU (1) AU2014278708B2 (enExample)
BR (1) BR112015031018B1 (enExample)
CA (1) CA2915174C (enExample)
CY (1) CY1119191T1 (enExample)
DK (1) DK3007716T3 (enExample)
ES (1) ES2631804T3 (enExample)
HU (1) HUE032970T2 (enExample)
MX (1) MX362846B (enExample)
MY (1) MY168981A (enExample)
PL (1) PL3007716T3 (enExample)
RU (1) RU2687151C2 (enExample)
SG (1) SG11201509048VA (enExample)
SI (1) SI3007716T1 (enExample)
TW (1) TWI511737B (enExample)
WO (1) WO2014200651A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110302088A (zh) * 2019-04-29 2019-10-08 杭州肽佳生物科技有限公司 一种包含修饰芋螺肽的化妆品组合物
AU2021211840B2 (en) * 2020-01-21 2024-08-29 Asc Regenity Ltd Cosmetic formulation for topical administration comprising novel peptides that improve appearance and regeneration of skin
PL245202B1 (pl) 2020-03-06 2024-06-03 Gdanski Univ Medyczny Lipopeptydowe koniugaty i ich sole, sposób wytwarzania lipopeptydowych koniugatów i ich soli, kompozycja farmaceutyczna zawierająca lipopeptydowy koniugat i jego sole do leczenia ran przewlekłych
WO2022098051A1 (ko) 2020-11-05 2022-05-12 한국생명공학연구원 항염 및 조직 재생작용을 갖는 신규 펩타이드
CN113698452B (zh) * 2021-08-23 2023-08-18 四川丽妍工坊生物科技有限公司 一种促皮肤修复肽、制备方法及其应用
EP4426715A1 (en) * 2021-11-02 2024-09-11 Enumita AS Tri-, tetra and pentapeptides, compositions thereof and their use in the therapy of psoriasis
US20240123022A1 (en) * 2021-12-16 2024-04-18 Ramakrishna Reddy ISANAKA A stable anti-angiogenic and anti-inflammatory pharmaceutical formulation and pharmaceutical combination for treatment and prevention of psoriasis
CN116407611A (zh) * 2021-12-29 2023-07-11 四川好医生攀西药业有限责任公司 一种多肽在制备预防或治疗皮肤损伤疾病产品上的应用
KR20230156265A (ko) 2022-05-03 2023-11-14 한국생명공학연구원 신규 펩타이드 및 이의 항염 및 재생 용도
KR20240086709A (ko) * 2022-11-18 2024-06-19 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130109614A1 (en) * 2011-10-26 2013-05-02 Jya-Wei Cheng Antagonists for diseases induced by cells with high-affinity elr-cxc chemokine receptor proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT62312A (en) * 1990-03-05 1993-04-28 Cephalon Inc Process for producing chymotrypsin-like proteases and their inhibitors
FR2814076B1 (fr) * 2000-09-21 2002-12-20 Centre Nat Rech Scient Agent angiogenique et ses utilisations
WO2007026356A2 (en) 2005-08-29 2007-03-08 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
PL2027152T3 (pl) 2006-06-13 2012-04-30 Helix Biomedix Inc Fragmenty peptydów do indukowania syntezy białek macierzy zewnątrzkomórkowej
JP2007001981A (ja) * 2006-07-10 2007-01-11 Nippon Meat Packers Inc 皮膚組織の再生及び肌質改善効果のあるペプチドを含有する化粧品
EP2125878B1 (en) 2007-01-05 2013-02-20 Helix Biomedix, Inc. Short bio-active peptides for cellular and immunological modulation
PL2205623T3 (pl) 2007-10-29 2016-09-30 Ochronne tetrapeptydy do pielęgnacji skóry
EP2109054A1 (en) * 2008-04-09 2009-10-14 Biotempt B.V. Methods for identifying biologically active peptides and predicting their function

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130109614A1 (en) * 2011-10-26 2013-05-02 Jya-Wei Cheng Antagonists for diseases induced by cells with high-affinity elr-cxc chemokine receptor proteins

Also Published As

Publication number Publication date
AU2014278708A1 (en) 2015-12-24
BR112015031018A2 (pt) 2018-09-25
KR20160018595A (ko) 2016-02-17
US20160184384A1 (en) 2016-06-30
ES2631804T3 (es) 2017-09-05
RU2687151C2 (ru) 2019-05-07
SI3007716T1 (sl) 2017-09-29
RU2015146679A (ru) 2017-07-17
CN105324122B (zh) 2019-08-27
TWI511737B (zh) 2015-12-11
KR102254260B1 (ko) 2021-05-20
US10195245B2 (en) 2019-02-05
MX2015017089A (es) 2016-04-11
RU2015146679A3 (enExample) 2018-03-21
MX362846B (es) 2019-02-19
CN105324122A (zh) 2016-02-10
HK1217436A1 (en) 2017-01-13
AR096594A1 (es) 2016-01-20
CA2915174C (en) 2019-10-29
EP3007716B1 (en) 2017-04-26
DK3007716T3 (en) 2017-07-31
CY1119191T1 (el) 2018-02-14
JP2016521746A (ja) 2016-07-25
HUE032970T2 (en) 2017-11-28
WO2014200651A1 (en) 2014-12-18
SG11201509048VA (en) 2015-12-30
TW201503896A (zh) 2015-02-01
MY168981A (en) 2019-01-29
CA2915174A1 (en) 2014-12-18
JP6416240B2 (ja) 2018-10-31
PL3007716T3 (pl) 2017-09-29
EP3007716A1 (en) 2016-04-20
BR112015031018B1 (pt) 2023-03-07
US20170007662A2 (en) 2017-01-12

Similar Documents

Publication Publication Date Title
DK3007716T3 (en) TETRAPEPTIDES DERIVED BY HUMAN C-X-C CHEMOKINES USED FOR TREATING DIFFERENT SKIN DISORDERS
CA2898717C (en) Short bio-active peptides for promoting wound healing
AU2013235692B2 (en) Short antimicrobial lipopeptides
RU2458069C2 (ru) Выделенный пептид для усиления ранозаживляющей активности кератиноцитов, композиция для заживления ран у млекопитающего и лекарственное средство для применения при заживлении ран у млекопитающего
ZHANG et al. GCC PATENT APPLICATION
HK1217436B (en) Tetrapeptides derived from human c-x-c chemokines useful for treatment of various skin conditions
HK1212243B (en) Short bio-active peptides for promoting wound healing
EP4701647A1 (en) Peptides with multivalent effects for topical use

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)